Analysis: Substance Abuse Admissions for Heroin Fall Following Adoption of Adult-Use Marijuana Legalization
UNIVERSITY PARK, PENNSYLVANIA — Substance use treatment admissions involving heroin are lower in states that have adopted adult-use marijuana legalization, according to new research from Pennsylvania State University.
The analysis, published in the International Journal of Drug Policy under the title “From medical authorization to adult-use retail: Cannabis policy stages and heroin involvement among US substance use treatment admissions,” drew on the federal Treatment Episode Data Set (TEDS). The researchers examined treatment admissions across all 50 states from 1992 through 2023.

Photo: Miguel Ausejo / Unsplash
Strongest effect in later adult-use stages
The researchers compared heroin involvement among admissions across cannabis policy stages, from medical authorization through adult-use retail, against states with no cannabis policy. Heroin involvement was lower during the adult-use stages than in states with no cannabis policy.

Image: NORML
The authors reported that the strongest evidence was for lower heroin involvement “during later adult-use policy stages relative to continued no-policy status.”

Photo: UX Indonesia / Unsplash
Part of a broader pattern
The findings add to a body of observational research linking legal cannabis access to fewer treatment admissions for opioid use and lower opioid-related mortality. Taken together, adult-use legalization and access are consistently associated with lower rates of heroin involvement among the public.
For states still weighing legalization, and for an industry that often points to public health outcomes in policy debates, three decades of national treatment data is a notable addition to the evidence.
Source: NORML (norml.org), “Analysis: Substance Abuse Admissions for Heroin Fall Following Adoption of Adult-Use Marijuana Legalization,” originally published November 19, 2026. Used with permission.






































